Randomized, 2-way Crossover, Pharmacokinetic Study of Lysteda (Xanodyne Modified-Immediate Release Tranexamic Acid) Tablets at 2 Doses in Fasting Adolescent Females With Evidence of Heavy Menstrual Bleeding.

Trial Profile

Randomized, 2-way Crossover, Pharmacokinetic Study of Lysteda (Xanodyne Modified-Immediate Release Tranexamic Acid) Tablets at 2 Doses in Fasting Adolescent Females With Evidence of Heavy Menstrual Bleeding.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2012

At a glance

  • Drugs Tranexamic acid (Primary)
  • Indications Menorrhagia
  • Focus Pharmacokinetics
  • Acronyms PREA
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 02 Jul 2012 Actual end date changed from May 2011 to Apr 2011 as reported by ClinicalTrials.gov.
    • 08 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top